These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Duloxetine: a balanced and selective norepinephrine- and serotonin-reuptake inhibitor. Westanmo AD; Gayken J; Haight R Am J Health Syst Pharm; 2005 Dec; 62(23):2481-90. PubMed ID: 16303903 [TBL] [Abstract][Full Text] [Related]
12. Painful diabetic neuropathy: many similarly effective therapies with widely dissimilar costs. Callaghan BC; Feldman EL Ann Intern Med; 2014 Nov; 161(9):674-5. PubMed ID: 25364890 [No Abstract] [Full Text] [Related]
13. Current views of diabetic peripheral neuropathic pain comorbid depression - a review. Wei KS; Gu MZ; Zhu JW; Hu HC; Yin LP Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10663-10670. PubMed ID: 33155224 [TBL] [Abstract][Full Text] [Related]
14. Duloxetine in the management of diabetic peripheral neuropathic pain. Ormseth MJ; Scholz BA; Boomershine CS Patient Prefer Adherence; 2011; 5():343-56. PubMed ID: 21845034 [TBL] [Abstract][Full Text] [Related]
15. A review of SSRIs and SNRIs in neuropathic pain. Lee YC; Chen PP Expert Opin Pharmacother; 2010 Dec; 11(17):2813-25. PubMed ID: 20642317 [TBL] [Abstract][Full Text] [Related]
16. Changes in opioid use and healthcare costs among U.S. patients with diabetic peripheral neuropathic pain treated with duloxetine compared with other therapies. Zhao Y; Wu N; Chen S; Boulanger L; Police RL; Fraser K Curr Med Res Opin; 2010 Sep; 26(9):2147-56. PubMed ID: 20662557 [TBL] [Abstract][Full Text] [Related]
17. Pharmacologic interventions for painful diabetic neuropathy: An umbrella systematic review and comparative effectiveness network meta-analysis. Griebeler ML; Morey-Vargas OL; Brito JP; Tsapas A; Wang Z; Carranza Leon BG; Phung OJ; Montori VM; Murad MH Ann Intern Med; 2014 Nov; 161(9):639-49. PubMed ID: 25364885 [TBL] [Abstract][Full Text] [Related]